Zacks Investment Research downgraded shares of LHC Group (NASDAQ:LHCG) from a buy rating to a hold rating in a research note published on Wednesday morning.
According to Zacks, “LHC Group, Inc. is the preferred post-acute care partner for hospitals, physicians and families nationwide. From home health and hospice care to long-term acute care and community-based services, LHC delivers high-quality, cost-effective care that empowers patients to manage their health at home. Hospitals and health systems around the country have partnered with LHC Group to deliver patient-centered care in the home. “
Other equities analysts have also issued reports about the company. Jefferies Financial Group lifted their price objective on LHC Group to $120.00 and gave the company a buy rating in a research note on Friday, August 3rd. Oppenheimer lifted their price objective on LHC Group from $85.00 to $110.00 and gave the company an outperform rating in a research note on Thursday, August 2nd. BidaskClub lowered LHC Group from a strong-buy rating to a buy rating in a research note on Tuesday, July 10th. SunTrust Banks raised their target price on LHC Group to $115.00 and gave the company a buy rating in a report on Thursday, September 13th. Finally, Cantor Fitzgerald initiated coverage on LHC Group in a report on Wednesday, September 12th. They set an overweight rating and a $117.00 target price on the stock. Four research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of Buy and an average target price of $105.64.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, meeting the consensus estimate of $0.95. The business had revenue of $507.00 million for the quarter, compared to analyst estimates of $515.03 million. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. The company’s revenue was up 88.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.64 EPS. On average, equities research analysts expect that LHC Group will post 3.52 EPS for the current fiscal year.
In other LHC Group news, COO Donald Dwayne Stelly sold 2,756 shares of LHC Group stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $99.32, for a total transaction of $273,725.92. Following the sale, the chief operating officer now directly owns 104,512 shares in the company, valued at approximately $10,380,131.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jeff Reibel sold 1,921 shares of LHC Group stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $94.12, for a total value of $180,804.52. Following the sale, the senior vice president now owns 8,125 shares in the company, valued at $764,725. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 79,677 shares of company stock worth $7,587,030. Company insiders own 6.80% of the company’s stock.
A number of hedge funds have recently bought and sold shares of LHCG. BlackRock Inc. increased its holdings in LHC Group by 76.9% during the 2nd quarter. BlackRock Inc. now owns 4,619,436 shares of the health services provider’s stock worth $395,377,000 after purchasing an additional 2,008,433 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of LHC Group by 74.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,133,200 shares of the health services provider’s stock valued at $182,581,000 after acquiring an additional 911,625 shares during the last quarter. FMR LLC increased its holdings in shares of LHC Group by 297.8% in the 2nd quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after acquiring an additional 861,952 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of LHC Group by 162.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock valued at $60,897,000 after acquiring an additional 439,947 shares during the last quarter. Finally, American Century Companies Inc. bought a new stake in shares of LHC Group in the 3rd quarter valued at approximately $35,964,000. Institutional investors own 86.50% of the company’s stock.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Featured Story: How to Use a Moving Average for Trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.